Trwa ładowanie...
Notowania

SPH sales revenues for January 2023

“Sopharma” AD (the Company) notifies that for January 2023 the Company recorded an increase in sales of 33% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 174% increase in export sales.

Załączniki

Inne komunikaty

DataTytułKursZmiana
2024-09-19
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
12,65
0,00
2024-09-18
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
-2,69
2024-09-17
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
0,00
2024-09-16
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
0,00
2024-09-13
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,20
-4,17
2024-09-12
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
-8,33
2024-09-11
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-10
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-10
SPH Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-09
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00